Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
of our product development teams building applications within the St. Jude Cloud ecosystem, including the large-scale data sharing application, Genomics Platform (https://platform.stjude.cloud
-
. We have an international patient population, which allows fellows to enhance their skills in working with diverse populations. St. Jude is consistently ranked by the U.S. News & World Report as a top
-
, research, committee work, etc.). St. Jude offers highly competitive stipends (currently 22% above NIH levels), health benefits (i.e., medical, prescription, dental, vision), and a professional development
-
to Work". St. Jude is one of the best-funded research institutes in the US with an annual budget of over $2 billion per year (https://www.stjude.org/about-st-jude/financials.html). What We Will Offer You
-
Job Description Join the Zhou lab ProteinPaint team (https://proteinpaint.stjude.org/team/) to contribute to the development of an open-source platform for biomedical data visualization, analysis
-
Glassdoor's "Best Places to Work". St. Jude is one of the best-funded research institutes in the US with an annual budget of over $2 billion per year (https://www.stjude.org/about-st-jude/financials.html). What
-
to Work". St. Jude is one of the best-funded research institutes in the US with an annual budget of over $2 billion per year (https://www.stjude.org/about-st-jude/financials.html). What We Will Offer You
-
, etc.). St. Jude offers highly competitive stipends (currently 22% above NIH levels), health benefits (i.e., medical, prescription, dental, vision), and a professional development allowance. Eligibility
-
of the best-funded research institutes in the US with an annual budget of over $2 billion per year (https://www.stjude.org/about-st-jude/financials.html). What You'll Do Assist in scheduling, tracking, and
-
international patient population, which allows fellows to enhance their skills in working with diverse populations. St. Jude is consistently ranked by the U.S. News & World Report as a top pediatric cancer